georgie18
7 hours ago
MBIO...26s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 670065
Friday, January 10, 2025 10:21:18 AM
Post#
671024
of 671059
MBIO...24s clearing here ...🥳Volume hitting...Hit .43 a few days ago...
georgie18
Member Level
Re: georgie18 post# 213
Thursday, January 02, 2025 10:59:21 AM
Post#
215
of 250
MBIO...38...🥳...Gonna be a big winner today...
georgie18
Member Level
Re: georgie18 post# 669337
Thursday, January 02, 2025 10:49:55 AM
Post#
670058
of 670064
MBIO...2979...🥳...Breaking out here...
georgie18
Member Level
Re: georgie18 post# 211
Friday, December 27, 2024 4:47:14 PM
Post#
212
of 212
MBIO....1927...🥳... https://schrts.co/SXHJicSE ...Reversal setting up here...imo...we shall see...
Member Level
Re: georgie18 post# 664533
Wednesday, December 04, 2024 8:24:43 AM
Post#
666634
of 669335
MBIO....1989...Been accumulating from .10 /30 range...🥳
georgie18
Member Level
Re: georgie18 post# 209
Tuesday, November 12, 2024 8:37:06 AM
Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.
MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html
georgie18
Member Level
Re: georgie18 post# 206
Wednesday, October 30, 2024 12:45:35 PM
Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...
georgie18
Member Level
Re: georgie18 post# 662593
Friday, October 25, 2024 2:32:02 PM
Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...
georgie18
10 hours ago
MBIO...24s clearing here ...🥳Volume hitting...Hit .43 a few days ago...
georgie18
Member Level
Re: georgie18 post# 213
Thursday, January 02, 2025 10:59:21 AM
Post#
215
of 250
MBIO...38...🥳...Gonna be a big winner today...
georgie18
Member Level
Re: georgie18 post# 669337
Thursday, January 02, 2025 10:49:55 AM
Post#
670058
of 670064
MBIO...2979...🥳...Breaking out here...
georgie18
Member Level
Re: georgie18 post# 211
Friday, December 27, 2024 4:47:14 PM
Post#
212
of 212
MBIO....1927...🥳... https://schrts.co/SXHJicSE ...Reversal setting up here...imo...we shall see...
Member Level
Re: georgie18 post# 664533
Wednesday, December 04, 2024 8:24:43 AM
Post#
666634
of 669335
MBIO....1989...Been accumulating from .10 /30 range...🥳
georgie18
Member Level
Re: georgie18 post# 209
Tuesday, November 12, 2024 8:37:06 AM
Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.
MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html
georgie18
Member Level
Re: georgie18 post# 206
Wednesday, October 30, 2024 12:45:35 PM
Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...
georgie18
Member Level
Re: georgie18 post# 662593
Friday, October 25, 2024 2:32:02 PM
Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...
Invest-in-America
1 week ago
MBIO: I don't have iHub's "Private Messaging" right now --- so, regarding your comments about our Pres. TRUMP down here, I didn't vote for him. However, since he wants to totally abandon that nasty "DAYLIGHT SAVINGS TIME" crap every year, well, I am beginning to LIKE Mr. Trump a lot MORE, every day!!!
georgie18
1 week ago
MBIO...38...🥳...Gonna be a big winner today...
georgie18
Member Level
Re: georgie18 post# 669337
Thursday, January 02, 2025 10:49:55 AM
Post#
670058
of 670064
MBIO...2979...🥳...Breaking out here...
georgie18
Member Level
Re: georgie18 post# 211
Friday, December 27, 2024 4:47:14 PM
Post#
212
of 212
MBIO....1927...🥳... https://schrts.co/SXHJicSE ...Reversal setting up here...imo...we shall see...
Member Level
Re: georgie18 post# 664533
Wednesday, December 04, 2024 8:24:43 AM
Post#
666634
of 669335
MBIO....1989...Been accumulating from .10 /30 range...🥳
georgie18
Member Level
Re: georgie18 post# 209
Tuesday, November 12, 2024 8:37:06 AM
Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.
MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html
georgie18
Member Level
Re: georgie18 post# 206
Wednesday, October 30, 2024 12:45:35 PM
Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...
georgie18
Member Level
Re: georgie18 post# 662593
Friday, October 25, 2024 2:32:02 PM
Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...
georgie18
1 week ago
MBIO...2979...🥳...Breaking out here...
georgie18
Member Level
Re: georgie18 post# 211
Friday, December 27, 2024 4:47:14 PM
Post#
212
of 212
MBIO....1927...🥳... https://schrts.co/SXHJicSE ...Reversal setting up here...imo...we shall see...
Member Level
Re: georgie18 post# 664533
Wednesday, December 04, 2024 8:24:43 AM
Post#
666634
of 669335
MBIO....1989...Been accumulating from .10 /30 range...🥳
georgie18
Member Level
Re: georgie18 post# 209
Tuesday, November 12, 2024 8:37:06 AM
Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.
MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html
georgie18
Member Level
Re: georgie18 post# 206
Wednesday, October 30, 2024 12:45:35 PM
Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...
georgie18
Member Level
Re: georgie18 post# 662593
Friday, October 25, 2024 2:32:02 PM
Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...
georgie18
2 weeks ago
MBIO....1927...🥳... https://schrts.co/SXHJicSE ...Reversal setting up here...imo...we shall see...
Member Level
Re: georgie18 post# 664533
Wednesday, December 04, 2024 8:24:43 AM
Post#
666634
of 669335
MBIO....1989...Been accumulating from .10 /30 range...🥳
georgie18
Member Level
Re: georgie18 post# 209
Tuesday, November 12, 2024 8:37:06 AM
Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.
MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html
georgie18
Member Level
Re: georgie18 post# 206
Wednesday, October 30, 2024 12:45:35 PM
Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...
georgie18
Member Level
Re: georgie18 post# 662593
Friday, October 25, 2024 2:32:02 PM
Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...
georgie18
1 month ago
MBIO....1989...Been accumulating from .10 /30 range...🥳
georgie18
Member Level
Re: georgie18 post# 209
Tuesday, November 12, 2024 8:37:06 AM
Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.
MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html
georgie18
Member Level
Re: georgie18 post# 206
Wednesday, October 30, 2024 12:45:35 PM
Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...
georgie18
Member Level
Re: georgie18 post# 662593
Friday, October 25, 2024 2:32:02 PM
Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...
georgie18
2 months ago
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.
MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html
georgie18
Member Level
Re: georgie18 post# 206
Wednesday, October 30, 2024 12:45:35 PM
Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...
georgie18
Member Level
Re: georgie18 post# 662593
Friday, October 25, 2024 2:32:02 PM
Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...